Merck subsidiary acquires Teqqa to help hospitals make antibiotic stewardship assessments
An estimated 23,000 deaths can be tied to antibiotic-resistance every year, according to data from the CDC's website.
presented by
What does the fund-raising environment currently look like within digital health? MedHeads guests piped in
Last Friday on our weekly MedHeads broadcast, we had a discussion about investment trends in digital health, current obstacles and what current startups should be conscious of going in.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
This week on MedHeads: A look at the fund-raising terrain for digital health companies
This week for MedHeads we'll be joined for this discussion by Dr. Dan Peterson, founder of Teqqa, which is focused on improving the treatment of infectious diseases and addressing the growing problem of antibiotic resistance, as well as, Lucas Felt president and CEO of The Medical Memory and Steve Kraus of Bessemer Venture Partners.
Epidemiologist uses analytics to help hospitals assess antibiotic stewardship
Dan Peterson is an epidemiologist and entrepreneur who started a company last year, Teqqa, to help physicians and healthcare facilities decide which antibiotics they should prescribe for their patients. Its first product — iAntibiogram — is an analytics tool for clinical decision support. It comes on the heels of the Obama administration’s push to improve […]
Antibiotic resistance tool marks Penn Medicine’s first equity investment in healthcare startup
It was supposed to be an innovation grant application. That was the initial idea when physician, disease hunter and entrepreneur Dan Peterson submitted a funding application for his healthcare software to address the big costly problem of antibiotic resistance. But as Dr. Amanda Christini, the director for strategic initiatives at the Center for Health Care Innovation, […]
Penn Medicine takes on antibiotic resistance risk in collaboration with health IT startup
Antibiotic resistance is a major public health threat caused partly by the overprescription of antibiotics. But bacteria’s resistance to commonly used antibiotics can vary depending on the region and the hospital. In a bid to build a better way to predict which antibiotics are most appropriate, Penn Medicine is collaborating with health IT startup Teqqa […]
presented by
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.